Index by author
March 01, 1994; Volume 22,Issue 2
A
Agostini, O
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Arison, B H
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
B
Balani, S K
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
- You have accessIn vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.T Prueksaritanont, L M Dwyer, S K Balani and A D TheoharidesDrug Metabolism and Disposition March 1994, 22 (2) 281-288;
Baldeck, J P
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
Bekersky, I
- You have accessThe pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.I Bekersky, R J Puhl, G Hanson and S MongDrug Metabolism and Disposition March 1994, 22 (2) 233-236;
Bonacchi, G
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Bork, V
- You have accessMilacemide metabolism in rat liver and brain slices by solids NMR.J R Garbow, W P Ridley, V Bork, Y Pan and J SchaeferDrug Metabolism and Disposition March 1994, 22 (2) 298-303;
Brouwer, K L
- You have accessBile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.A B Suttle and K L BrouwerDrug Metabolism and Disposition March 1994, 22 (2) 224-232;
Bruelisauer, A
- You have accessAbsorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.A Bruelisauer, R Kawai, P Misslin and M LemaireDrug Metabolism and Disposition March 1994, 22 (2) 194-199;
C
Chen, Q
- You have accessSalicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.I M Darling, M L Mammarella, Q Chen and M E MorrisDrug Metabolism and Disposition March 1994, 22 (2) 318-323;
Chenery, R J
- You have accessUse of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.A W Harrell, S M Wheeler, P East, S E Clarke and R J CheneryDrug Metabolism and Disposition March 1994, 22 (2) 189-193;
Cheng, X
- You have accessSolvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.X Cheng, C Maniglier-Poulet, D Ross and J A RuthDrug Metabolism and Disposition March 1994, 22 (2) 206-210;
Clarke, S E
- You have accessUse of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.A W Harrell, S M Wheeler, P East, S E Clarke and R J CheneryDrug Metabolism and Disposition March 1994, 22 (2) 189-193;
Cole, C A
- You have accessCharacterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.R F Mayol, C A Cole, G M Luke, K L Colson and E H KernsDrug Metabolism and Disposition March 1994, 22 (2) 304-311;
Colletti, A E
- You have accessDisposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.A E Colletti and P A KrieterDrug Metabolism and Disposition March 1994, 22 (2) 183-188;
Collins, J M
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Colson, K L
- You have accessCharacterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.R F Mayol, C A Cole, G M Luke, K L Colson and E H KernsDrug Metabolism and Disposition March 1994, 22 (2) 304-311;
Coppini, G
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
D
Dalgaard, L
- You have accessPharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.L Dalgaard, R K Hjortkjaer, B Regnier and L NordholmDrug Metabolism and Disposition March 1994, 22 (2) 289-293;
Darling, I M
- You have accessSalicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.I M Darling, M L Mammarella, Q Chen and M E MorrisDrug Metabolism and Disposition March 1994, 22 (2) 318-323;
Dwyer, L M
- You have accessIn vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.T Prueksaritanont, L M Dwyer, S K Balani and A D TheoharidesDrug Metabolism and Disposition March 1994, 22 (2) 281-288;
E
East, P
- You have accessUse of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.A W Harrell, S M Wheeler, P East, S E Clarke and R J CheneryDrug Metabolism and Disposition March 1994, 22 (2) 189-193;
Egorin, M J
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Erkmen, K
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
F
Faiman, M D
- You have accessNADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.A Madan and M D FaimanDrug Metabolism and Disposition March 1994, 22 (2) 324-330;
Fischer, V
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
Forkert, P G
- You have accessInduction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.P G Forkert, Z M Redza, S Mangos, S S Park and S P TamDrug Metabolism and Disposition March 1994, 22 (2) 248-253;
G
Garbow, J R
- You have accessMilacemide metabolism in rat liver and brain slices by solids NMR.J R Garbow, W P Ridley, V Bork, Y Pan and J SchaeferDrug Metabolism and Disposition March 1994, 22 (2) 298-303;
Garland, W A
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
Goldman, M E
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
H
Hanson, G
- You have accessThe pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.I Bekersky, R J Puhl, G Hanson and S MongDrug Metabolism and Disposition March 1994, 22 (2) 233-236;
Harrell, A W
- You have accessUse of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.A W Harrell, S M Wheeler, P East, S E Clarke and R J CheneryDrug Metabolism and Disposition March 1994, 22 (2) 189-193;
Heitz, F
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
Henderson, L
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
Hjortkjaer, R K
- You have accessPharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.L Dalgaard, R K Hjortkjaer, B Regnier and L NordholmDrug Metabolism and Disposition March 1994, 22 (2) 289-293;
Hoffman, J M
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Horecký, J
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
I
Iba, K
- You have accessPharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.M Yabuki, T Mine, K Iba, I Nakatsuka and A YoshitakeDrug Metabolism and Disposition March 1994, 22 (2) 294-297;
J
Jamis-Dow, C A
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Jensen, B K
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
Juchau, M R
- You have accessCytochrome P-450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary, and cardiac tissues.M J Namkung, H L Yang and M R JuchauDrug Metabolism and Disposition March 1994, 22 (2) 331-337;
K
Kállay, Z
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
Kauffman, L R
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Kawai, R
- You have accessAbsorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.A Bruelisauer, R Kawai, P Misslin and M LemaireDrug Metabolism and Disposition March 1994, 22 (2) 194-199;
Kerns, E H
- You have accessCharacterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.R F Mayol, C A Cole, G M Luke, K L Colson and E H KernsDrug Metabolism and Disposition March 1994, 22 (2) 304-311;
Khetarpal, V K
- You have accessDispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.V K Khetarpal, P M Markham and J A ZiemniakDrug Metabolism and Disposition March 1994, 22 (2) 216-223;
Khokhar, A R
- You have accessPharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.Y Kido, A R Khokhar, M Yoshida, G W Thai and Z H SiddikDrug Metabolism and Disposition March 1994, 22 (2) 312-317;
Kido, Y
- You have accessPharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.Y Kido, A R Khokhar, M Yoshida, G W Thai and Z H SiddikDrug Metabolism and Disposition March 1994, 22 (2) 312-317;
Klecker, R W
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Krejcy, K
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
Krieter, P A
- You have accessDisposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.A E Colletti and P A KrieterDrug Metabolism and Disposition March 1994, 22 (2) 183-188;
L
Lemaire, M
- You have accessAbsorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.A Bruelisauer, R Kawai, P Misslin and M LemaireDrug Metabolism and Disposition March 1994, 22 (2) 194-199;
Luke, G M
- You have accessCharacterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.R F Mayol, C A Cole, G M Luke, K L Colson and E H KernsDrug Metabolism and Disposition March 1994, 22 (2) 304-311;
M
Madan, A
- You have accessNADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.A Madan and M D FaimanDrug Metabolism and Disposition March 1994, 22 (2) 324-330;
Mahadevan, S
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
Mammarella, M L
- You have accessSalicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.I M Darling, M L Mammarella, Q Chen and M E MorrisDrug Metabolism and Disposition March 1994, 22 (2) 318-323;
Mangos, S
- You have accessInduction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.P G Forkert, Z M Redza, S Mangos, S S Park and S P TamDrug Metabolism and Disposition March 1994, 22 (2) 248-253;
Maniglier-Poulet, C
- You have accessSolvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.X Cheng, C Maniglier-Poulet, D Ross and J A RuthDrug Metabolism and Disposition March 1994, 22 (2) 206-210;
Manzini, S
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Marathe, P H
- You have accessMetabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.P H Marathe, D D Shen and W L NelsonDrug Metabolism and Disposition March 1994, 22 (2) 237-247;
Markham, P M
- You have accessDispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.V K Khetarpal, P M Markham and J A ZiemniakDrug Metabolism and Disposition March 1994, 22 (2) 216-223;
Mayol, R F
- You have accessCharacterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.R F Mayol, C A Cole, G M Luke, K L Colson and E H KernsDrug Metabolism and Disposition March 1994, 22 (2) 304-311;
Mine, T
- You have accessPharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.M Yabuki, T Mine, K Iba, I Nakatsuka and A YoshitakeDrug Metabolism and Disposition March 1994, 22 (2) 294-297;
Minery, P
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
Misslin, P
- You have accessAbsorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.A Bruelisauer, R Kawai, P Misslin and M LemaireDrug Metabolism and Disposition March 1994, 22 (2) 194-199;
Moneti, G
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Mong, S
- You have accessThe pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.I Bekersky, R J Puhl, G Hanson and S MongDrug Metabolism and Disposition March 1994, 22 (2) 233-236;
Morris, M E
- You have accessSalicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.I M Darling, M L Mammarella, Q Chen and M E MorrisDrug Metabolism and Disposition March 1994, 22 (2) 318-323;
N
Nakatsuka, I
- You have accessPharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.M Yabuki, T Mine, K Iba, I Nakatsuka and A YoshitakeDrug Metabolism and Disposition March 1994, 22 (2) 294-297;
Namkung, M J
- You have accessCytochrome P-450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary, and cardiac tissues.M J Namkung, H L Yang and M R JuchauDrug Metabolism and Disposition March 1994, 22 (2) 331-337;
Nelson, W L
- You have accessMetabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.P H Marathe, D D Shen and W L NelsonDrug Metabolism and Disposition March 1994, 22 (2) 237-247;
Nordholm, L
- You have accessPharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.L Dalgaard, R K Hjortkjaer, B Regnier and L NordholmDrug Metabolism and Disposition March 1994, 22 (2) 289-293;
O
O'Brien, J A
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Olah, T V
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
P
Pan, Y
- You have accessMilacemide metabolism in rat liver and brain slices by solids NMR.J R Garbow, W P Ridley, V Bork, Y Pan and J SchaeferDrug Metabolism and Disposition March 1994, 22 (2) 298-303;
Park, S S
- You have accessInduction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.P G Forkert, Z M Redza, S Mangos, S S Park and S P TamDrug Metabolism and Disposition March 1994, 22 (2) 248-253;
Parker, R J
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Pieraccini, G
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Piotrovskij, V K
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
Prueksaritanont, T
- You have accessIn vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.T Prueksaritanont, L M Dwyer, S K Balani and A D TheoharidesDrug Metabolism and Disposition March 1994, 22 (2) 281-288;
Puhl, R J
- You have accessThe pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.I Bekersky, R J Puhl, G Hanson and S MongDrug Metabolism and Disposition March 1994, 22 (2) 233-236;
R
Raberger, G
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
Ramjit, H G
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Redza, Z M
- You have accessInduction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.P G Forkert, Z M Redza, S Mangos, S S Park and S P TamDrug Metabolism and Disposition March 1994, 22 (2) 248-253;
Regnier, B
- You have accessPharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.L Dalgaard, R K Hjortkjaer, B Regnier and L NordholmDrug Metabolism and Disposition March 1994, 22 (2) 289-293;
Ridley, W P
- You have accessMilacemide metabolism in rat liver and brain slices by solids NMR.J R Garbow, W P Ridley, V Bork, Y Pan and J SchaeferDrug Metabolism and Disposition March 1994, 22 (2) 298-303;
Rooney, C S
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Ross, D
- You have accessSolvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.X Cheng, C Maniglier-Poulet, D Ross and J A RuthDrug Metabolism and Disposition March 1994, 22 (2) 206-210;
Rubio, F
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
Ruth, J A
- You have accessSolvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.X Cheng, C Maniglier-Poulet, D Ross and J A RuthDrug Metabolism and Disposition March 1994, 22 (2) 206-210;
S
Schaefer, J
- You have accessMilacemide metabolism in rat liver and brain slices by solids NMR.J R Garbow, W P Ridley, V Bork, Y Pan and J SchaeferDrug Metabolism and Disposition March 1994, 22 (2) 298-303;
Shen, D D
- You have accessMetabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.P H Marathe, D D Shen and W L NelsonDrug Metabolism and Disposition March 1994, 22 (2) 237-247;
Siddik, Z H
- You have accessPharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.Y Kido, A R Khokhar, M Yoshida, G W Thai and Z H SiddikDrug Metabolism and Disposition March 1994, 22 (2) 312-317;
Stevens, R
- You have accessEffect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.R W Klecker, C A Jamis-Dow, M J Egorin, K Erkmen, R J Parker, R Stevens and J M CollinsDrug Metabolism and Disposition March 1994, 22 (2) 254-258;
Suttle, A B
- You have accessBile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.A B Suttle and K L BrouwerDrug Metabolism and Disposition March 1994, 22 (2) 224-232;
Szuna, A
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
T
Tam, S P
- You have accessInduction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.P G Forkert, Z M Redza, S Mangos, S S Park and S P TamDrug Metabolism and Disposition March 1994, 22 (2) 248-253;
Thai, G W
- You have accessPharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.Y Kido, A R Khokhar, M Yoshida, G W Thai and Z H SiddikDrug Metabolism and Disposition March 1994, 22 (2) 312-317;
Theoharides, A D
- You have accessIn vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.T Prueksaritanont, L M Dwyer, S K Balani and A D TheoharidesDrug Metabolism and Disposition March 1994, 22 (2) 281-288;
Toja, E
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Town, C
- You have accessDisposition of [14C]acitretin in humans following oral administration.F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C TownDrug Metabolism and Disposition March 1994, 22 (2) 211-215;
Triolo, A
- You have accessMetabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G MonetiDrug Metabolism and Disposition March 1994, 22 (2) 259-268;
Trnovec, T
- You have accessNG-nitro-L-arginine is not involved in enterohepatic cycling in rats.V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K KrejcyDrug Metabolism and Disposition March 1994, 22 (2) 338-339;
Tynes, R
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
V
Varga, S L
- You have accessMetabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M HoffmanDrug Metabolism and Disposition March 1994, 22 (2) 200-205;
Vickers, A E
- You have accessThe polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R TynesDrug Metabolism and Disposition March 1994, 22 (2) 269-274;
W
Wheeler, S M
- You have accessUse of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.A W Harrell, S M Wheeler, P East, S E Clarke and R J CheneryDrug Metabolism and Disposition March 1994, 22 (2) 189-193;
Y
Yabuki, M
- You have accessPharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.M Yabuki, T Mine, K Iba, I Nakatsuka and A YoshitakeDrug Metabolism and Disposition March 1994, 22 (2) 294-297;
Yang, H L
- You have accessCytochrome P-450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary, and cardiac tissues.M J Namkung, H L Yang and M R JuchauDrug Metabolism and Disposition March 1994, 22 (2) 331-337;
Yoshida, M
- You have accessPharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.Y Kido, A R Khokhar, M Yoshida, G W Thai and Z H SiddikDrug Metabolism and Disposition March 1994, 22 (2) 312-317;
Yoshida, T
- You have accessPharmacokinetic study of p-chloronitrobenzene in rat.T YoshidaDrug Metabolism and Disposition March 1994, 22 (2) 275-280;
Yoshitake, A
- You have accessPharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.M Yabuki, T Mine, K Iba, I Nakatsuka and A YoshitakeDrug Metabolism and Disposition March 1994, 22 (2) 294-297;
Z
Ziemniak, J A
- You have accessDispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.V K Khetarpal, P M Markham and J A ZiemniakDrug Metabolism and Disposition March 1994, 22 (2) 216-223;
In this issue

Advertisement